Concepedia

Bihter Atil

BA

Statistics

Publications

5

Citations

308

H-Index

5

Active since

2010

Affiliations

Medical University of Vienna(Current)

University of Vienna

BOKU University

Comprehensive Cancer Center Vienna

Bihter Atil is an author at Medical University of Vienna specializing in pharmacology, oncology, and molecular oncology.

Publications per year

2010–2015

5

Publications

5

Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339

Petra Heffeter, Katharina Böck, Bihter Atil et al. · JBIC Journal of Biological Inorganic Chemistry · 2010 · 170 citations

Medicine, Oncology, Pharmacology +14

The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo

Petra Heffeter, Bihter Atil, Kushtrim Kryeziu et al. · European Journal of Cancer · 2013 · 84 citations · Full text

Medicine, Oncology, Pharmacology +13

In vitro and in vivo downregulation of the ATP binding cassette transporter B1 by the HMG-CoA reductase inhibitor simvastatin

Bihter Atil, Evelyn Berger–Sieczkowski, Johanna Bardy et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2015 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17

Simvastatin-induced compartmentalisation of doxorubicin sharpens up nuclear topoisomerase II inhibition in human rhabdomyosarcoma cells

Martin Werner, Bihter Atil, Evelyn Berger–Sieczkowski et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2013 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

Tocilizumab unmasks a stage-dependent interleukin-6 component in statin-induced apoptosis of metastatic melanoma cells

Christoph Minichsdorfer, Christine Wasinger, Evelyn Berger–Sieczkowski et al. · Melanoma Research · 2015 · 12 citations · Full text

Life Sciences, Oncology, Pharmacology +17

1–5 of 5